SAN DIEGO–Robbins Umeda LLP has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by members of the Board of Directors of Symyx Technologies, Inc. (“Symyx”) (NASDAQ: SMMX – News) in connection with their actions in causing Symyx to enter into a definitive merger agreement with Accelrys, Inc. (“Accelrys”) […]
HILLSBORO, Ore. — — FEI Company (Nasdaq:FEIC), a leading diversified scientific instruments company, announced that it has filed suit in the United States District Court for the Eastern District of Virginia to collect approximately $2.4 million of receivables owed to FEI by Cambridge Global Systems of Chantilly, VA. Cambridge Global Systems, a subsidiary of Cambridge […]
NEW YORK–Enzo Biochem Inc. (NYSE:ENZ – News) said today that a decision released Friday by the Court of Appeals for the Federal Circuit reversing a district court’s summary judgment will enable the Company to pursue a claim for substantial damages against Applera Corporation, now Life Technologies Corporation. (NASDAQ: LIFE – News). The Court of Appeals […]
HOPKINTON, Mass. — Caliper Life Sciences, Inc. (Nasdaq: CALP), a leading provider of tools and services for drug discovery and life sciences research, today announces that it has entered into a settlement agreement with Shimadzu Corporation and its wholly owned subsidiary Shimadzu Scientific Instruments, Inc., resolving a lawsuit filed by Caliper in the United States […]
Confirms Cellectis’ Loss of Patent Protection for Single-Chain Meganucleases in Europe RESEARCH TRIANGLE PARK, N.C.–Precision BioSciences, Inc., today announced that the Opposition Division of the European Patent Office (EPO) has issued a written decision confirming its November 18, 2009 revocation of the previously granted claims of Cellectis’ European Patent No. 1 485 475. As previously […]
RESEARCH TRIANGLE PARK, N.C.–Precision BioSciences, Inc., today announced that the United States Patent and Trademark Office (PTO) has issued non-final Actions Closing Prosecution in the reexamination proceedings for U.S. Pat. Nos. 6,833,252 (“the ‘252 patent”) and 7,214,536 (“the ‘536 patent”) that are owned by the Institut Pasteur and the Universite Pierre et Marie Cure (UPMC), […]
NEW YORK–Enzo Biochem, Inc., (NYSE:ENZ) today announced that the Board of Patent Appeals and Interferences of the United States Patent and Trademark Office has entered judgment in favor of Enzo and against Bayer HealthCare LLC in a patent interference proceeding relating to Enzo Life Science’s application for nucleic acid signal amplification and Bayer’s U.S. Patent […]
BENSALEM, Pa.–Law Offices of Howard G. Smith announces that it is investigating potential claims against the board of directors of Millipore Corporation (“Millipore” or the “Company”) (NYSE:MIL – News) related to a reported offer to acquire the Company by Thermo Fisher Scientific Inc. (“Thermo Fisher”). The reported offer is valued at approximately $6 billion, including […]
HOPKINTON, Mass. — Caliper Life Sciences, Inc. (Nasdaq:CALP – News), a leading provider of tools and services for drug discovery and life sciences research, and its wholly owned subsidiary Xenogen Corporation, today announced the filing of a patent infringement lawsuit in the U.S. District Court for the Eastern District of Texas. In the suit, filed […]
Agilent Technologies Wins HPLC Columns Trade Secrets Case Against Advanced Materials Technology, Inc
SANTA CLARA, Calif.–Agilent Technologies Inc. (NYSE: A) today announced a favorable decision in its trade secrets and breach of contract case against Advanced Materials Technology, Inc. (AMT) and three of its employees in the Delaware Court of Chancery. Agilent filed the lawsuit in January 2008 to protect confidential and proprietary information relating to its high-performance […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
